United Therapeutics Corp (NASDAQ:UTHR) shares, rose in value on Friday, March 07, with the stock price up by 2.67% to the previous day’s close as strong demand from buyers drove the stock to $315.91.
Actively observing the price movement in the last trading, the stock closed the session at $307.68. The PE ratio was 12.84 over 12-month period. Referring to stock’s 52-week performance, its high was $417.82, and the low was $221.53. On the whole, UTHR has fluctuated by -10.81% over the past month.
With the market capitalization of United Therapeutics Corp currently standing at about $14.19 billion, investors are eagerly awaiting this quarter’s results, scheduled for in April.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 3.15B, with a low estimate of 714.4M and a high estimate of 750.7M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 729.27M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that UTHR’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the PEG ratio is about 1.69, with the price of UTHR currently trading nearly -8.06% and -10.89% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 34.44, while the 7-day volatility ratio is showing 3.33% which for the 30-day chart, stands at 3.65%. Furthermore, United Therapeutics Corp (UTHR)’s beta value is 0.64, and its average true range (ATR) is 12.45.
A comparison of United Therapeutics Corp (UTHR) with its peers suggests the former has fared considerably weaker in the market. UTHR showed an intraday change of 2.67% in last session, and over the past year, it grew by 37.47%%.
Data on historical trading for United Therapeutics Corp (NASDAQ:UTHR) indicates that the trading volumes over the past 3 months, they’ve averaged 405.18K. According to company’s latest data on outstanding shares, there are 44.83 million shares outstanding.
Nearly 1.89% of United Therapeutics Corp’s shares belong to company insiders and institutional investors own 99.75% of the company’s shares. The stock has fallen by -10.47% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the UTHR stock heading into the next quarter.
